Wednesday, February 10, 2010, 1:03am EST - Canadian Markets open in 8 hours and 27 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Strategic Diagnostics Inc. (SDIX)

On Feb 9: 1.44 USD  Up 0.02 (1.41%)  
MORE ON SDIX
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Strategic Diagnostics Inc. (NGM:SDIX) Delayed quote dataEdit
Last Trade: 1.44 USD
Trade Time: Feb 9
Change: Up 0.02 (1.41%)
Prev Close: 1.42
Open: 1.46
Bid: 1.07 x 1000
Ask: 1.87 x 1000
1y Target Est: 4.97
Day's Range: 1.40 - 1.47
52wk Range: 0.85 - 2.25
Volume: 5,495
Avg Vol (3m): 18,539.7
Market Cap: 29.35M
P/E (ttm): 24.83
EPS (ttm): 0.06
Div & Yield: N/A (N/A%)
Strategic Diagnostics Inc. (SDIX)
1d  5d  3m  6m  1y  2y  5y  max 
 Add SDIX to Portfolio   Download Data

HEADLINES
Dr. Klaus Lindpaintner Begins Serving as Vice President of R&D and CSO for Strategic Diagnostics
Business Wire (Wed, Feb 3)
SDI Selected Again to Produce Monoclonal Antibodies for SAIC-F to Advance Cancer Research
Business Wire (Mon, Feb 1)
Strategic Diagnostics RapidChek® E. coli O157 System Awarded AOAC Research Institute Certification for Composite Testing of Raw Beef Products
Business Wire (Tue, Jan 19)
Dr. Klaus Lindpaintner Joins SDI as Vice President of R&D / Chief Scientific Officer
Business Wire (Mon, Jan 11)
SDI Collaborates with Fred Hutchinson Cancer Research Center to Discover Biomarkers for Use in Early Detection of Cancer
Business Wire (Wed, Jan 6)
STRATEGIC DIAGNOSTICS INC/DE/ Financials
EDGAR Online Financials (Fri, Nov 20)
STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 16)
STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
EDGAR Online (Thu, Oct 29)
STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Fri, Sep 4)
STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Aug 14)
More Headlines for SDIX...

ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 1.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Strategic Diagnostics, Inc. engages in the development, manufacture, and marketing of antibody products and analytical test kits for a range of food, water, agricultural, industrial, environmental, and scientific applications primarily in the Unit...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices